bioRxiv Science⌕ Search

bioRxiv · 10.1101/2024.12.17.628963

Combined biosynthesis and site-specific incorporation of phenylalanine derivatives from aryl aldehydes or carboxylic acids in engineered bacteria

Abstract

Applications of genetic code expansion in live cells are widespread and continually emerging, yet they have been limited by their reliance on the supplementation of non-standard amino acids (nsAAs) to cell culturing media. While advances in cell-free biocatalysis are improving nsAA synthesis cost and sustainability, such processes remain reliant on multi-step processes of product isolation followed by supplementation to engineered cells. Here, we report the design of a modular and genetically encoded system that combines the steps of biosynthesis of diverse phenylalanine derivatives, which are the most frequently used family of nsAAs for genetic code expansion, and their site-specific incorporation within target proteins using a single engineered bacterial host. Unlike previous demonstrations in which individual nsAAs were targeted for biosynthesis and site-specific incorporation, our system serves as a platform that exhibits broad substrate specificity towards commercially ubiquitous, achiral building blocks of aryl aldehydes or carboxylic acids. We demonstrate that this modular system enables high fidelity biosynthesis and incorporation of nsAAs for multiple industrially relevant nsAAs, such as the incorporation of 4,4-L-biphenylalanine within proteins after supplementation with biphenylaldehyde and the incorporation of 4-azido-L-phenylalanine within proteins after supplementation with 4-azido-benzoic acid. Finally, we show that the combination of nsAA biosynthesis and incorporation steps can extend the chemical reach of the intrinsic biological containment strategy of synthetic auxotrophy from nsAAs to low-cost and achiral building blocks. We anticipate that our system will aid industrial-scale manufacturing of proteins that contain nsAAs and democratize access to expensive or commercially unavailable chemistries for labs that lack separations or synthesis expertise.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Anderson, S., Spangler, A. P., Jones, M. A., Dickey, R. M., Kunjapur, A. M.. 2024-12-18. Combined biosynthesis and site-specific incorporation of phenylalanine derivatives from aryl aldehydes or carboxylic acids in engineered bacteria. https://doi.org/10.1101/2024.12.17.628963

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Programmable interphyla communication for Staphylococcus aureus by transferability of homoserine lactone sensors between Bacillales bacteria

Staphylococcus aureus is a Gram-positive opportunistic pathogen of the order Bacillales and a frequent member of human-associated microbiomes. Despite its clinical relevance, engineering S. aureus and the communities it inhabits remains limited by a shortage of well-characterized genetic tools for precise control of gene expression and intercellular signaling. Biosensors for homoserine lactones (HSLs) are widely used in Gram-negative bacteria, as HSLs are small, passively diffusible signaling molecules for and their sensors are tightly regulated. Here, we show that synthetically designed HSL sensors using LuxR-family regulators are highly functional in S. aureus. Notably, synthetic designs previously built for the Gram-positive model Bacillus subtilis, a distantly related Bacillales, transferred functionally and establish repurposing the genetic toolbox as an effective strategy for importing these functions into S. aureus. Sensor performance correlated strongly between the two Bacillales, and activation in S. aureus reached 55-fold, exceeding the dynamic range of reported inducible systems. We further demonstrate tightly regulated, programmable interphyla communication between Gram-negative Escherichia coli and S. aureus via HSL signaling. These results provide a new toolset for engineering interbacterial communication and open a route to extending programmable HSL signaling to other tough-to-engineer bacteria.

synthetic biology↗

DIALECT: DNA-Programmable Synthetic Cells Communicate with Mammalian Cells through Synthetic Receptors

Synthetic cells can regulate mammalian signalling through the controlled release of diffusible protein ligands, but coupling programmable synthetic-cell senders to orthogonal, engineered mammalian receptors remains challenging. Here we present DIALECT (DNA-Instructed Assembly of Ligands for Engineered Cellular Transduction), a platform in which proteinosome-based synthetic cells translate sequence-defined DNA inputs into coiled-coil signalling ligand outputs for engineered mammalian receptors. DNA-ligand conjugates are localized within semipermeable proteinosomes through DNA hybridization and released by toehold-mediated DNA strand displacement (TMSD). The released ligands diffuse to neighbouring mammalian cells and activate cognate CC-GEMS receptors, inducing JAK/STAT3 signalling and reporter activation, with a higher response in cognate than non-cognate receiver cells under activation conditions. We further implement distributed Boolean AND logic using two independently programmed proteinosome populations that respond to distinct DNA inputs and release complementary ligand components. Simultaneous addition of both inputs produces substantially higher reporter activity than the respective single-input conditions, consistent with extracellular assembly of an active receptor agonist. DIALECT thus establishes a modular interface linking DNA-based molecular computation in synthetic cells to orthogonal signalling pathways in mammalian cells, providing a foundation for hybrid artificial-biological communication networks.

synthetic biology↗

Intracellular bio-synthesizing Gold Nanoparticles using bacterial systems and their applications in photothermal therapy (A green approach)

Background: Conventional cancer therapies are heavily constrained by systemic toxicity, off-target side effects, and poor deep-tissue penetration due to the highly heterogeneous tumor microenvironment (TME). Although gold nanoparticles (AuNPs) possess exceptional localized surface plasmon resonance (LSPR) properties ideal for photothermal therapy (PTT), their clinical translation is bottlenecked by inconsistent passive accumulation and chemical toxicity arising from conventional synthetic surfactants. Objective: This study developed a sustainable, biocompatible bio-hybrid platform utilizing the probiotic Escherichia coli Nissle 1917 (EcN) as an autonomous, tumor-homing living carrier integrated with AuNPs synthesized via an eco-friendly intracellular green chemistry approach. Methods: EcN cultures were prepared in Luria-Bertani (LB) medium and subsequently exposed to a 1 mM chloroauric acid (HAuCl4) metallic precursor. A facile, room-temperature green synthesis protocol was established by utilizing ascorbic acid (Vitamin C) as a non-toxic co-reductant to drive a seed-mediated crystallization onto intra-bacterial metallic seeds. The bio-hybrid system (EcN::AuNPs) was characterized via visual inspection, UV-Vis spectroscopy, and in vitro PTT assays under continuous-wave near-infrared (NIR) laser irradiation. Results: Visual confirmation showed an irreversible color shift from pale yellow to a deep dark-brownish hue, serving as a direct diagnostic indicator of successful Au3+ to Au0 reduction. UV-Vis spectroscopic analysis revealed a distinct, broadened surface plasmon resonance (SPR) band centered at 560nm, indicating the formation of stabilized, isotropic gold nanostructures (30-60nm) subjected to near-field electromagnetic coupling within the complex intracellular compartments (periplasm and cytoplasm). Biocompatibility assays demonstrated a significant collapse in cell viability from 10^8CFU/mL down to 10^3CFU/mL, driven by a combination of trivalent gold heavy-metal toxicity, mechanical disruption of the peptidoglycan wall from spatial confinement, and severe metabolic/oxidative stress. Nevertheless, the remaining surviving population maintained required active chemotactic capabilities, while the lysed bacterial matrix provided a natural protein capping layer that prevented nanoparticle aggregation. Under 5 minutes of continuous NIR laser irradiation, the EcN::AuNPs platform exhibited exceptional concentration-dependent hyperthermia kinetics, triggering a drastic thermal escalation from 20 C to an absolute peak of 75.4 C, vastly outperforming all baseline control groups (pure EcN, bare HAuCl4, and standalone ascorbic acid). Conclusion: The engineered EcN::AuNPs bio-hybrid platform represents a highly efficient and biosafe "bacteriobot" paradigm. By shifting the SPR footprint and leveraging the native bacterial cell envelope for colloidal stability, this system achieves an optimal equilibrium between active biological tumor targeting and rapid, localized photothermal ablation, offering a promising alternative for targeted oncological interventions.

synthetic biology↗